The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?
- 1 July 2012
- journal article
- conference paper
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 126 (1), 5-11
- https://doi.org/10.1016/j.ygyno.2012.04.040
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2Journal of Clinical Oncology, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2008
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical stagingGynecologic Oncology, 2008
- Lymphadenectomy in endometrioid uterine cancer stagingCancer, 2007
- The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005Gynecologic Oncology, 2007
- Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2006
- Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2005
- The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatmentGynecologic Oncology, 2004
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Conservative Management of Stage I Endometrial Carcinoma after Surgical StagingGynecologic Oncology, 2002